Pegulicianine (Lumisight)
Reconstitution onlyFull monograph review pending
U.S. label preparation
Lumisight · Reconstitution only
- Preparation
- Reconstitute each vial with 4 mL of 0.45% sodium chloride only (10 mg/mL). The label specifies 3.9 mL withdrawable per vial.
- Administration and handling
- The 0.9% sodium chloride used for the line flush is a different concentration from the reconstitution fluid.
Product and source details
Lumicell, Inc. · NDA214511
Product NDC: 82292-040
SPL effective 2026-01-09 | SPL version 3. Checked 2026-11-13.
Source for this summary: U.S. prescribing information. Use the full label for dose selection, contraindications, preparation tables and monitoring.
Product identifiers and clinical review status
U.S. label preparation available. Full monograph review pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- Obtain independent corroboration of the label preparation where available.
- Complete indication- and age-specific dosing, incompatibility, monitoring and stability review.
- Assess any proposed compounding BUD for the exact formulation, concentration, container and conditions.